Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- Check4 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page. No actual study data or essential content changes are introduced.SummaryDifference0.1%

- Check11 days agoChange DetectedRemoved the 'Type 2 diabetes' condition from the page’s Conditions section. The related topics header and the MedlinePlus Genetics entry were also removed, affecting navigation and external-resource links.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision upgraded from v3.5.3 to v3.5.4, signaling a small internal update to the page’s tooling. No substantive content changes to the study details are indicated by this update.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a minor update to the page record rather than substantive changes to the study information.SummaryDifference0.1%

- Check54 days agoChange DetectedSite revision updated to v3.5.2; v3.5.0 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Type 2 diabetes as a related topic and included MedlinePlus Genetics as related topics. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.